Literature DB >> 10209817

Equine glanders in Turkey.

S Arun1, H Neubauer, A Gürel, G Ayyildiz, B Kusçu, T Yesildere, H Meyer, W Hermanns.   

Abstract

In the course of an epidemiological study of glanders on a number of Turkish islands in the Sea of Marmara, 1128 horses were examined by using the intracutaneous mallein test. Thirty-five (3-1 per cent) developed an increase in rectal temperature and a swelling at the point of injection. Ten of these horses were killed and glanders was confirmed in five cases by the presence of lesions and by the immunohistological demonstration of the causative agent, Burkholderia mallei. Clinical and pathological findings indicated that in all cases the infection was restricted to the mucous membrane of the nasal cavity with its parasinus, the nostrils and the upper lips. It was confirmed that equine glanders is endemic in Turkey.

Entities:  

Mesh:

Year:  1999        PMID: 10209817     DOI: 10.1136/vr.144.10.255

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  24 in total

1.  Use of a recombinant burkholderia intracellular motility a protein for immunodiagnosis of glanders.

Authors:  Subodh Kumar; Praveen Malik; Shailendra Kumar Verma; Vijai Pal; Vandana Gautam; Chiranjay Mukhopadhyay; Ganga Prasad Rai
Journal:  Clin Vaccine Immunol       Date:  2011-07-13

2.  Antibodies against In Vivo-Expressed Antigens Are Sufficient To Protect against Lethal Aerosol Infection with Burkholderia mallei and Burkholderia pseudomallei.

Authors:  Shawn M Zimmerman; Jeremy S Dyke; Tomislav P Jelesijevic; Frank Michel; Eric R Lafontaine; Robert J Hogan
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

3.  Evaluation of PCR, DNA hybridization and immunomagnetic separation - PCR for detection of Burkholderia mallei in artificially inoculated environmental samples.

Authors:  S Merwyn; S Kumar; G S Agarwal; G P Rai
Journal:  Indian J Microbiol       Date:  2010-03-05       Impact factor: 2.461

4.  Use of Immunohistochemistry to Demonstrate In Vivo Expression of the Burkholderia mallei Virulence Factor BpaB During Experimental Glanders.

Authors:  Shawn M Zimmerman; Mackenzie E Long; Jeremy S Dyke; Tomislav P Jelesijevic; Frank Michel; Eric R Lafontaine; Robert J Hogan
Journal:  Vet Pathol       Date:  2017-11-16       Impact factor: 2.221

5.  Present and future therapeutic strategies for melioidosis and glanders.

Authors:  D Mark Estes; Steven W Dow; Herbert P Schweizer; Alfredo G Torres
Journal:  Expert Rev Anti Infect Ther       Date:  2010-03       Impact factor: 5.091

6.  Evaluation of recombinant proteins of Burkholderia mallei for serodiagnosis of glanders.

Authors:  Vijai Pal; Subodh Kumar; Praveen Malik; Ganga Prasad Rai
Journal:  Clin Vaccine Immunol       Date:  2012-06-13

7.  DISCRIMINATION OF Burkholderia mallei/pseudomallei FROM Burkholderia thailandensis BY SEQUENCE COMPARISON OF A FRAGMENT OF THE RIBOSOMAL PROTEIN S21 (RPSU) GENE.

Authors:  H Frickmann; N Chantratita; Y P Gauthier; H Neubauer; R M Hagen
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-06-13

8.  Virulence of Burkholderia mallei quorum-sensing mutants.

Authors:  Charlotte Majerczyk; Loren Kinman; Tony Han; Richard Bunt; E Peter Greenberg
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

9.  Development and validation of a method for purification of mallein for the diagnosis of glanders in equines.

Authors:  Maurício Baltazar de Carvalho Filho; Rodrigo Mauro Ramos; Antônio Augusto Fonseca; Lívia de Lima Orzil; Mariana Lázaro Sales; Vania Lucia de Assis Santana; Marcilia Maria Alves de Souza; Evandro Dos Reis Machado; Paulo Rodrigues Lopes Filho; Rômulo Cerqueira Leite; Jenner Karlisson Pimenta Dos Reis
Journal:  BMC Vet Res       Date:  2012-09-02       Impact factor: 2.741

10.  Effectiveness of an antimicrobial treatment scheme in a confined glanders outbreak.

Authors:  Muhammad Saqib; Ghulam Muhammad; Abeera Naureen; Muhammad H Hussain; M Nadeem Asi; M Khalid Mansoor; Mehdi Toufeer; Iahtasham Khan; Heinrich Neubauer; Lisa D Sprague
Journal:  BMC Vet Res       Date:  2012-11-07       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.